Filing Details

Accession Number:
0001209191-20-048491
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-27 08:40:54
Reporting Period:
2020-08-26
Accepted Time:
2020-08-27 08:40:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
944809 Opko Health Inc. OPK Pharmaceutical Preparations (2834) 752402409
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1381874 D Steven Rubin Opko Health, Inc.
4400 Biscayne Blvd.
Miami FL 33137
Executive Vp-Administration Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-26 5,000 $3.99 6,162,732 No 4 P Direct
Common Stock Acquisiton 2020-08-26 2,500 $3.99 6,165,232 No 4 P Direct
Common Stock Acquisiton 2020-08-26 2,500 $4.01 6,167,732 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Includes 413,585 shares received as a pro rata distribution from The Frost Group, LLC ("The Frost Group"), of which the reporting person is a member. The Frost Group effected a pro rata distribution of its 20,091,062 shares of the Issuer, pursuant to which reporting person now has direct beneficial ownership of his pro rata share of the securities formerly held by The Frost Group. The reporting person previously reported that the shares were owned directly by The Frost Group.